0001708138-21-000026.txt : 20210623
0001708138-21-000026.hdr.sgml : 20210623
20210623160245
ACCESSION NUMBER: 0001708138-21-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210621
FILED AS OF DATE: 20210623
DATE AS OF CHANGE: 20210623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YANCOPOULOS GEORGE
CENTRAL INDEX KEY: 0001226690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 211038740
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-06-21
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001226690
YANCOPOULOS GEORGE
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
President and Chief Scientific
Common Stock
2021-01-12
5
G
0
82108
0.0
A
82108
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
738
532.89
D
81370
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
7494
533.66
D
73876
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
8236
534.48
D
65640
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
4154
535.63
D
61486
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
3768
536.37
D
57718
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
6636
537.61
D
51082
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
4868
538.54
D
46214
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
3306
539.66
D
42908
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
8099
540.61
D
34809
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
19911
541.44
D
14898
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
10514
542.43
D
4384
I
By Trust for Chldn.
Common Stock
2021-06-21
4
S
0
2276
543.13
D
2108
I
By Trust for Chldn.
Common Stock
987483
D
Common Stock
5845
I
By 401(k) Plan
Common Stock
211585
I
by 2019 GRAT
Class A Stock
2021-04-15
4
G
0
14000
0.0
A
Common Stock
14000
14000
I
By Tr. for Daughter
Class A Stock
2021-04-15
4
G
0
14000
0.0
D
Common Stock
14000
0
I
by Daughter
Class A Stock
2021-04-15
4
G
0
5383
0.0
D
Common Stock
5383
0
I
by Son
Class A Stock
2021-04-15
4
G
0
5383
0.0
A
Common Stock
5383
5383
I
by Trust for Son
As investment trustee of trusts for the benefit of the reporting person's children.
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 738 shares of Company stock on June 21, 2021 at prices ranging from $532.56 to $532.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Represents volume-weighted average price of sales of 7,494 shares of Company stock on June 21, 2021 at prices ranging from $533.14 to $533.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Represents volume-weighted average price of sales of 8,236 shares of Company stock on June 21, 2021 at prices ranging from $534.01 to $534.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Represents volume-weighted average price of sales of 4,154 shares of Company stock on June 21, 2021 at prices ranging from $535.05 to $535.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Represents volume-weighted average price of sales of 3,768 shares of Company stock on June 21, 2021 at prices ranging from $536.02 to $536.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Represents volume-weighted average price of sales of 6,636 shares of Company stock on June 21, 2021 at prices ranging from $537.05 to $537.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Represents volume-weighted average price of sales of 4,868 shares of Company stock on June 21, 2021 at prices ranging from $538.01 to $538.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Represents volume-weighted average price of sales of 3,306 shares of Company stock on June 21, 2021 at prices ranging from $539.14 to $539.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Represents volume-weighted average price of sales of 8,099 shares of Company stock on June 21, 2021 at prices ranging from $540.00 to $540.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Represents volume-weighted average price of sales of 19,911 shares of Company stock on June 21, 2021 at prices ranging from $541.00 to $541.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Represents volume-weighted average price of sales of 10,514 shares of Company stock on June 21, 2021 at prices ranging from $542.00 to $542.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Represents volume-weighted average price of sales of 2,276 shares of Company stock on June 21, 2021 at prices ranging from $543.01 to $543.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 21, 2021 at each separate price.
Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder.
These shares of Class A Stock are presently convertible and such conversion feature does not expire.
These shares of Class A Stock are held in a trust for the benefit of the reporting person's child, of which the reporting person is trustee.
These shares of Class A Stock were held in custody for the benefit of the reporting person's child.
/s/**George D. Yancopoulos
2021-06-23